LRMR - Latest News

Larimar Therapeutics, Inc. (LRMR), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $350.9M. Beta to the broader market is 0.91.

The article list below shows the most recent LRMR headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent LRMR Headlines

Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update

globenewswire.com - May 14, 2026

Intending to initiate rolling BLA seeking accelerated approval with submission of nonclinical and clinical modules in June 2026; submission of the fin

Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich's Ataxia

globenewswire.com - Apr 30, 2026

BALA CYNWYD, Pa. , April 30, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Recommendation of “Buy” by Brokerages

defenseworld.net - Apr 27, 2026

Shares of Larimar Therapeutics, Inc. (NASDAQ: LRMR - Get Free Report) have been assigned a consensus recommendation of "Buy" from the ten ratings fir

Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

globenewswire.com - Mar 19, 2026

* Pro forma cash, cash equivalents, and marketable securities of $244. 5 million reflects $136.

Investors Buy Large Volume of Larimar Therapeutics Call Options (NASDAQ:LRMR)

defenseworld.net - Mar 15, 2026

Larimar Therapeutics, Inc. (NASDAQ: LRMR - Get Free Report) was the target of some unusual options trading activity on Friday.

How News Affects LRMR Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track LRMR's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked LRMR news questions

What is the latest LRMR news headline?
The most recent LRMR headline (May 14, 2026) is "Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the LRMR news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What LRMR news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual LRMR options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.